CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center
O que está incluído neste pacote
Procedimentos médicos
- Terapia com células T CAR
- 3 refeições por dia pelo nutricionista
- Serviços de enfermagem 24 horas
- Tomografia Computadorizada
- Exames de sangue
- Exame de acompanhamento
- Ultrassom
- Ecocardiografia
- Exame de sangue para bioquímica
- PET/TC
- Consulta com um onco-hematologista
- Hemograma completo com marcadores tumorais e proteinograma
Duração
- 21 dias no hospital
- 7 dias no hotel
Acomodação
Hospitalização
Transporte
Transfer aeroporto-clínica-aeroporto
Informações adicionais
CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center
For patients facing relapsed or resistant Non-Hodgkin lymphoma, finding the right treatment center can make a life-changing difference.
Sheba Medical Center, one of the world’s leading hospitals, offers advanced CAR-T cell therapy, providing new hope when standard treatments are no longer effective.
Sheba specializes in treating DLBCL, Follicular Lymphoma (FL), and Mantle Cell Lymphoma (MCL) with a highly personalized approach, combining cutting-edge science, speed, and clinical expertise.
A Faster Path to Treatment When Time Matters Most
At Sheba, the entire CAR-T process is performed on-site, without delays caused by external laboratories.
• T-cells are collected (apheresis)
• Genetically engineered at Sheba’s Advanced Biotherapy Center
• Reinfused to target and destroy lymphoma cells
This streamlined approach allows treatment to begin in approximately 10 days, significantly faster than many international centers.
CAR-T therapy acts as a “living drug”, continuing to work inside the body and offering the potential for long-term remission.
All patients are treated under the leadership of Prof. Arnon Nagler, a world-renowned expert in hemato-oncology.
Proven Results That Offer Real Hope
Even in complex and advanced cases, CAR-T therapy at Sheba has demonstrated high remission rates:
• Up to 90% in pediatric patients
• ~80% in young adults (up to 23 years old)
• ~70% in adults
These outcomes provide a meaningful second chance for patients who have exhausted other options.
Why Patients Choose Sheba
• Rapid access to treatment – no waiting weeks for cell production
• Extensive experience – one of the largest CAR-T programs in the region
• Dedicated CAR-T units – with 24/7 expert monitoring
• Multidisciplinary care – leading specialists working together on every case
• Full international support – from medical review to travel and coordination
Comprehensive, Personalized Care
Each patient undergoes a complete evaluation, including advanced imaging, genetic and molecular testing, and full medical assessment, ensuring the most effective, tailored treatment plan.
Services are available in English, Russian, and Arabic, making the experience smooth and supportive for international patients.
A Global Leader in Advanced Cancer Care
By combining speed, innovation, and world-class expertise, Sheba delivers one of the most advanced and accessible CAR-T programs for lymphoma patients worldwide, offering not just treatment, but a real opportunity for remission and renewed quality of life.
Assistência Bookimed 24/7
- Coordenador médico pessoal
- Arranjos de viagem médica — reserva de passagens aéreas e quartos de hotel com preços especiais de parceiros
- Defesa do paciente durante a viagem médica
Preço do programa
O que NÃO está incluído neste pacote
Médico
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Como estamos indo?
Sobre a clínica
A terapia com células CAR-T no Sheba Medical Center em Tel Aviv, Israel, pode custar cerca de US$ 63.100 pelo programa completo. O hospital está entre os 10 melhores do mundo e oferece este tratamento avançado sob a coordenação do Prof. Arnon Nagler, um renomado especialista em transplante de medula óssea.
Sobre o Tratamento
A terapia com células CAR-T é uma abordagem inovadora para leucemia, linfoma e mieloma múltiplo. O processo envolve a coleta das células T do paciente, sua modificação genética em laboratório e a reinfusão após a quimioterapia. O procedimento exige 21 dias de internação hospitalar, com possibilidade de permanência na UTI.
O que está incluído
- Avaliação abrangente (US$ 5.000 - US$ 10.000)
- Coleta de células via aférese (US$ 6.600)
- Preparação laboratorial das células modificadas (US$ 20.000)
- Quimioterapia de condicionamento (US$ 5.000)
- Internação de 21 dias (US$ 31.500)
- Avaliação pós-tratamento (US$ 3.000 - US$ 5.000)
Preparação e Recuperação
Os pacientes necessitam de biópsia de medula óssea, exames de PET/CT e exames de sangue antes do tratamento. Após a infusão, ocorre o monitoramento diário para a síndrome de liberação de citocinas. A permanência total recomendada em Israel é de 4 a 6 semanas. Vale ressaltar que o CAR-T para mieloma ainda é experimental.
O Sheba Medical Center atende 1,5 milhão de pacientes anualmente e oferece atendimento multilíngue. É necessário um depósito de US$ 50.000 a US$ 60.000 antes da chegada. Entre em contato com o hospital para avaliar se esta terapia é adequada para o seu caso.
Pagamento e Recompensas
Não pague por nossos serviços
Efetue o pagamento diretamente na clínica ou na conta bancária oficial dela.
Algumas clínicas podem exigir um depósito como parte de sua política.
Divida seus pagamentos com opções de parcelamento.
Ganhe recompensas por indicar amigos ao Bookimed.